✦ LIBER ✦

Demyelination occurring during anti–tumor necrosis factor α therapy for inflammatory arthritides

✍ Scribed by Niveditha Mohan; Evelyne T. Edwards; Thomas R. Cupps; Patrick J. Oliverio; Glenn Sandberg; Heidi Crayton; John R. Richert; Jeffrey N. Siegel

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 611 KB
Volume: 44
Category: Article
ISSN: 0004-3591
DOI: 10.1002/1529-0131(200112)44:12<2862::aid-art474>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-tumor necrosis factor-α therapies f

Anti-tumor necrosis factor-α therapies for immune-mediated and inflammatory skin diseases

✍ Clio Dessinioti; Alexander J. Stratigos; Andreas Katsambas; Christina Antoniou 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Psoriasis during anti–tumor necrosis fac

Psoriasis during anti–tumor necrosis factor-alpha therapy for Crohn's disease

✍ Junji Umeno; Takayuki Matsumoto; Yukihiko Jo; Miki Ichikawa; Kazunori Urabe; Mit 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Anti–tumor necrosis factor α therapy in

Anti–tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacy

✍ Jacques-Eric Gottenberg; Florence Merle-Vincent; Fabrice Bentaberry; Yannick All 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Liver diseases associated with anti-tumo

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha

Successful rechallenge with anti–tumor n

Successful rechallenge with anti–tumor necrosis factor α for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: Comment on the article by Mohan et al

✍ Marcela Cisternas; Miguel Gutiérrez; Sergio Jacobelli 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

Differences in the incidence of flares o

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents

✍ Braun, J. ;Baraliakos, X. ;Listing, J. ;Davis, J. ;van der Heijde, D. ;Haibel, H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## Objective Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are clinically and pathologically linked. Anti–tumor necrosis factor (anti‐TNF) agents are efficacious in treating AS, but not all are equally effective in treating IBD (Crohn's disease [CD] and ulcerative co